Eyedrops Instead of Reading Glasses – Company Begins Ph IIb Trial

Orasis Pharmaceuticals LTD., a clinical stage pharmaceutical company developing a corrective eye drop for the treatment of presbyopia as an alternative to reading glasses, announced on 3/27/19 the initiation of a  Phase 2b clinical study  in the U.S. evaluating CSF-1 for the treatment of presbyopia.